Funding
Funding
Our Funding
The total funding of the CRUK Manchester Institute and the CRUK National Biomarker Centre for 2024 was £17.1m. The major source of this funding was awarded by Cancer Research UK (CRUK) via a core grant of £11m, plus additional strategic funding of £0.4m. This funding enables the various scientific groups and service units within the Institute to carry out their research.
The infrastructure of the CRUK Manchester Institute is funded by Research England generated income at a cost of £2.1m.
The balance of the Institute’s funding is received from a number of additional sources. The research carried out through these additional projects enhances and supports the research undertaken by the core funding.
These sources are as follows:
- Blood Cancer UK
- CellCentric
- Christie Hospital NHS Foundation Trust
- European Commission
- European Research Council
We are immensely grateful to all our funders.
- Harry J Lloyd Charitable Trust
- Imago Bioscience
- Lustgarten Foundation
- Medical Research Council
- Melanoma Research Alliance
- National Institute of Health Research
- NC3Rs
- Ono Pharmaceuticals
- Pancreatic Cancer Research Fund